March 05, 2018
Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting
Media
February 28, 2018
Nexstim Financial Statements Release 2017
February 27, 2018
Nordic Nanovector ASA – Results for the Fourth Quarter and Full Year 2017: Solid performance through 2017, moving forward with pivotal trial
February 21, 2018
Wilson Therapeutics AB (Publ) Year-End Report 2017
February 20, 2018
BONESUPPORT™ HOLDING AB (Publ) – Q4 and 2017 Year-End Report – January – December
February 20, 2018
GenSight Biologics announces publication of positive data from Phase I/II trial and long-term follow-up of GS010 in Ophthalmology, the journal of the American Academy of Ophthalmology
February 20, 2018
Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast
February 19, 2018
SAVE THE DATE: Wilson Therapeutics to Host Capital Markets Day in Stockholm on 21 March 2018
February 16, 2018
Notice of Nexstim Plc 2017 Full Year Results
February 16, 2018
First patient enrolled in pivotal Phase 3 FOCuS trial evaluating WTX101 for the treatment of Wilson Disease
